Epidemiology of multidrug-resistant tuberculosis in low- and middle-income countries

@inproceedings{Espinal2000EpidemiologyOM,
  title={Epidemiology of multidrug-resistant tuberculosis in low- and middle-income countries},
  author={Marcos A. Espinal},
  year={2000}
}
  • Marcos A. Espinal
  • Published 2000
  • Medicine
  • Drug-resistant tuberculosis (TB) was reported soon after the introduction of streptomycin [1], although it did not receive major attention until recently [2,3]. It was not considered a major issue in the industrialized world until outbreaks of multidrug-resistant TB (MDRTB), defined as resistance to at least isoniazid and rifampicin, were reported among HIV-infected people [4– 7]. There has been an increasing concern on how drug-resistant TB and, more specifically, MDRTB is, or will be… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv